Literature DB >> 8206951

Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.

Y Umayahara1, R Kawamori, H Watada, E Imano, N Iwama, T Morishima, Y Yamasaki, Y Kajimoto, T Kamada.   

Abstract

As a step toward elucidating the physiological role of insulin-like growth factor-I (IGF-I) in mediating estrogen action, we sought to determine the molecular basis of the phenomenon. In HepG2 cells expressing exogenous estrogen receptors (ER), a reporter gene plasmid containing 600 base pairs of the chicken IGF-I promoter enhanced expression of luciferase 8.6-fold in response to 10(-6) M 17 beta-estradiol, indicating that the IGF-I promoter is a target of estrogen regulation. Although no conventional estrogen-responsive element was identified within the promoter fragment, the AP-1 motif located therein was shown to be essential; the estrogen-responsive enhancement of the Fos-Jun binding to the AP-1 motif, which takes place by means of post-translational modification, mediates the estrogen action. A direct or indirect interaction between the estrogen-ER complex and the Fos-Jun complex seems to facilitate the Fos-Jun binding to the target DNA. Although ER binding to the target DNA was not considered to be involved in the signaling pathway, the DNA binding domain-deficient ER did not mediate the phenomenon, providing support for the existence of a unique function of the DNA binding domain of ER in facilitating some protein-protein interaction. In conclusion, our present observations demonstrate that the chicken IGF-I gene promoter is controlled by estrogen through a unique pathway involving Fos, Jun, and the DNA binding domain of ER.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206951

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression.

Authors:  Daigo Sumi; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

Review 3.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

Review 4.  The changing role of ER in endocrine resistance.

Authors:  Agostina Nardone; Carmine De Angelis; Meghana V Trivedi; C Kent Osborne; Rachel Schiff
Journal:  Breast       Date:  2015-08-10       Impact factor: 4.380

5.  Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1.

Authors:  Edwin Cheung; Mari Luz Acevedo; Philip A Cole; W Lee Kraus
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

Review 6.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 7.  Bioactivation of Selective Estrogen Receptor Modulators (SERMs).

Authors:  Tamara S Dowers; Zhi-Hui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2006-09       Impact factor: 3.739

8.  Canonical pathways and networks regulated by estrogen in the bovine mammary gland.

Authors:  Robert W Li; Anthony V Capuco
Journal:  Funct Integr Genomics       Date:  2007-08-01       Impact factor: 3.410

9.  Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta.

Authors:  Premlata Kumar; Amrita Kamat; Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2009-03-19

10.  Differential gene regulation by the SRC family of coactivators.

Authors:  Hua Zhang; Xia Yi; Xiaojing Sun; Na Yin; Bin Shi; Huijian Wu; Dan Wang; Ge Wu; Yongfeng Shang
Journal:  Genes Dev       Date:  2004-07-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.